Pharmos (PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ariella who wrote (444)	2/3/1999 7:42:00 AM
From: crysball	Read Replies (1) of 1386

Thinking Caps Ariella, good thought, but Human and Organizaional Behavior can limit logic. The Adage "We do what we like, we do what we know best and then finally we do what needs to be done" seems to apply to PARS. As previously noted, PARS went throgh a period of the 'Scientists in the Candy Store' and made thier choices, then proceeded to run behind schedule and over budget to arrive at their current state of affairs, which has severely limited their options going forward........for example they haven't even brought Tamoxifen forward. Given their limited financial and human resources they are managing them well.........but the strategic errors were made some time ago, and management must work through the current resouce limitations imposed by those choices. My greatest concern is that once a strategic partner is signed up for HU-211 and they finally become profitable (in 99), they will lose foucus and staff up and resume the 'Scientist in the Candy store approach as resource limitations ease up.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next